{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T11:28:05Z","timestamp":1769081285546,"version":"3.49.0"},"reference-count":40,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>We have previously shown that the Wnt canonical pathway (WCP) is constitutively active in most cases of mantle cell lymphoma (MCL). Here, we aimed to elucidate the mechanisms underlying this biochemical deregulation. We hypothesized that gene methylation\/silencing of WIF1 (Wnt inhibitory factor-1), a physiologic inhibitor of WCP, contributes to the deregulation of WCP and promotes cell growth in MCL. In support of this hypothesis, we found that the expression of WIF1 was detectable in none of the 4 MCL cell lines, and in only 2 of 5 tumors (40%) examined. Using methylation-specific PCR, we found evidence of gene methylation of WIF1 in 4 of 5 cell lines (80%) and in 24 of 29 (82%) tumors. The addition of the demethylation agent 5-aza-2\u2032-deoxycytidine to Mino and JeKo-1, two WIF1-negative cell lines, restored the expression of WIF1 mRNA in these cells. Gene transfection of WIF1 into JeKo-1 and Mino cells significantly reduced cell growth, and this finding correlated with substantial downregulations of various proteins in WCP, such as \u03b2-catenin and pGSK-3\u03b2. In conclusion, our results support the concept that gene methylation\/silencing of WIF1 is a frequent event in MCL, and this abnormality contributes to the aberrant activation of WCP. These results have provided further evidence that aberrant Wnt signaling is pathogenetically important in MCL and it may represent a potential therapeutic target.<\/jats:p>","DOI":"10.3390\/ijms22020893","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T05:17:34Z","timestamp":1610947054000},"page":"893","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gene Methylation and Silencing of WIF1 Is a Frequent Genetic Abnormality in Mantle Cell Lymphoma"],"prefix":"10.3390","volume":"22","author":[{"given":"Abdulraheem","family":"Alshareef","sequence":"first","affiliation":[{"name":"Medical Laboratories Technology Department, College of Applied Medical Sciences, Taibah University, Madinah, P.O. Box 41477, Saudi Arabia"},{"name":"Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2E1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2570-339X","authenticated-orcid":false,"given":"Anthea C.","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alberta, Edmonton, AB T6G 2E1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2434-8987","authenticated-orcid":false,"given":"Pascal","family":"G\u00e9l\u00e9bart","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2E1, Canada"},{"name":"Department of Clinical Science, University of Bergen, 5021 Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Will","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2E1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6963-2407","authenticated-orcid":false,"given":"Raymond","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2E1, Canada"},{"name":"Department of Oncology, University of Alberta, Edmonton, AB T6G 2E1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clml.2017.10.004","article-title":"A Systematic Review of Treatments of Relapsed\/Refractory Mantle Cell Lymphoma","volume":"18","author":"Parrott","year":"2018","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_2","first-page":"1136","article-title":"Current overview and treatment of mantle cell lymphoma","volume":"7","author":"Schieber","year":"2018","journal-title":"Research"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: Biology, pathogenesis, and the molecular basis of treatment in the genomic era","volume":"117","author":"Dreyling","year":"2011","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/15384101.2019.1706903","article-title":"The double dealing of cyclin D1","volume":"19","author":"Tchakarska","year":"2020","journal-title":"Cell Cycle"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1172\/JCI96520","article-title":"Cyclin D1 overexpression induces global transcriptional downregulation in lymphoid neoplasms","volume":"128","author":"Albero","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1038\/ncomms11581","article-title":"Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin","volume":"7","author":"Cemeli","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.leu.2404177","article-title":"Murine model for mantle cell lymphoma","volume":"20","author":"Smith","year":"2006","journal-title":"Leukemia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-016-0349-z","article-title":"A positive feedback loop involving the Wnt\/\u03b2-catenin\/MYC\/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphoma","volume":"9","author":"Wu","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/s41388-020-1183-x","article-title":"Stabilization of beta-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma","volume":"39","author":"Lazarian","year":"2020","journal-title":"Oncogene"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41375-019-0404-1","article-title":"Aberrant Wnt signaling in multiple myeloma: Molecular mechanisms and targeting options","volume":"33","author":"Kocemba","year":"2019","journal-title":"Leukemia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7150\/thno.37423","article-title":"WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer","volume":"10","author":"Radaszkiewicz","year":"2020","journal-title":"Theranostics"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13045-015-0161-1","article-title":"Targeting Wnt pathway in mantle cell lymphoma-initiating cells","volume":"8","author":"Mathur","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood.V112.11.2253.2253","article-title":"Acute Myeloid Leukemia Is Characterized by Wnt Pathway Inhibitor Promoter Methylation","volume":"112","author":"Griffiths","year":"2008","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/onc.2016.304","article-title":"Wnt signaling in cancer","volume":"36","author":"Zhan","year":"2017","journal-title":"Oncogene"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4103\/jcrt.JCRT_421_18","article-title":"Targeting the canonical Wnt\/\u03b2-catenin pathway in cancer radioresistance: Updates on the molecular mechanisms","volume":"15","author":"Yang","year":"2019","journal-title":"J. Cancer Res. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3389\/fonc.2019.01248","article-title":"Multiple Targets of the Canonical WNT\/\u03b2-Catenin Signaling in Cancers","volume":"9","author":"Lecarpentier","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_17","first-page":"244","article-title":"Biological and clinical significance of GSK-3beta in mantle cell lymphoma--an immunohistochemical study","volume":"3","author":"Chung","year":"2010","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1182\/blood-2008-02-139212","article-title":"Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma","volume":"112","author":"Gelebart","year":"2008","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1182\/blood-2011-07-370122","article-title":"Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis","volume":"119","author":"Iqbal","year":"2012","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1017\/S0029665118000150","article-title":"The role of DNA methylation in ageing and cancer","volume":"77","author":"Morgan","year":"2018","journal-title":"Proc. Nutr. Soc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.gene.2019.06.023","article-title":"Gene promoter methylation and cancer: An umbrella review","volume":"710","author":"Bouras","year":"2019","journal-title":"Gene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e14588","DOI":"10.1097\/MD.0000000000014588","article-title":"Hypermethylation of tumor suppressor genes is a risk factor for poor prognosis in ovarian cancer: A meta-analysis","volume":"98","author":"Feng","year":"2019","journal-title":"Medicine"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Pfeifer, G.P. (2018). Defining Driver DNA Methylation Changes in Human Cancer. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19041166"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"a026948","DOI":"10.1101\/cshperspect.a026948","article-title":"DNA Hypomethylating Drugs in Cancer Therapy","volume":"7","author":"Sato","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/asheducation-2017.1.45","article-title":"How and when to decide between epigenetic therapy and chemotherapy in patients with AML","volume":"2017","author":"Dombret","year":"2017","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/17474086.2018.1453802","article-title":"Epigenetic therapy: Azacytidine and decitabine in acute myeloid leukemia","volume":"11","author":"Bohl","year":"2018","journal-title":"Expert Rev. Hematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcell.2018.00167","article-title":"An Eye on the Wnt Inhibitory Factor Wif1","volume":"6","author":"Poggi","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbrc.2013.07.123","article-title":"Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer","volume":"438","author":"Tan","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/0973-1482.235357","article-title":"Promoter methylation of WNT inhibitory factor-1 may be associated with the pathogenesis of multiple human tumors","volume":"14","author":"Zhou","year":"2018","journal-title":"J. Cancer Res. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3892\/ol.2017.5566","article-title":"WIF-1 gene inhibition and Wnt signal transduction pathway activation in NSCLC tumorigenesis","volume":"13","author":"Tang","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Liu, X., Fu, J., Bi, H., Ge, A., Xia, T., Liu, Y., Sun, H., Li, D., and Zhao, Y. (2019). DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-6436-0"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.3892\/mmr.2017.7564","article-title":"Hypermethylation of WIF1 and its inhibitory role in the tumor growth of endometrial adenocarcinoma","volume":"16","author":"Deng","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1182\/blood-2019-131020","article-title":"PRMT5 Is a Key Epigenetic Regulator That Promotes Transcriptional Activation in Mantle Cell Lymphoma By Regulating the Lysine Methyltransferase SETD7 and MLL1 Activity","volume":"134","author":"Chung","year":"2019","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3892\/or.2017.5425","article-title":"miR-181a-5p, an inducer of Wnt-signaling, facilitates cell proliferation in acute lymphoblastic leukemia","volume":"37","author":"Lyu","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1349-7006.2008.00884.x","article-title":"Methylation status of Wnt signaling pathway genes affects the clinical outcome of Philadelphia-positive acute lymphoblastic leukemia","volume":"99","author":"Martin","year":"2008","journal-title":"Cancer Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.leukres.2005.12.005","article-title":"Infrequent Wnt inhibitory factor-1 (Wif-1) methylation in chronic lymphocytic leukemia","volume":"30","author":"Chim","year":"2006","journal-title":"Leuk. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7946","DOI":"10.1038\/sj.onc.1208910","article-title":"Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers","volume":"24","author":"Taniguchi","year":"2005","journal-title":"Oncogene"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1158\/0008-5472.CAN-04-1389","article-title":"Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer","volume":"64","author":"Mazieres","year":"2004","journal-title":"Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10059-013-0060-7","article-title":"Wif1 hypermethylation as unfavorable prognosis of non-small cell lung cancers with EGFR mutation","volume":"36","author":"Lee","year":"2013","journal-title":"Mol. Cells"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/2\/893\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:12:14Z","timestamp":1760159534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/2\/893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,18]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["ijms22020893"],"URL":"https:\/\/doi.org\/10.3390\/ijms22020893","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,18]]}}}